Equillium Inc

NASDAQ:EQ   12:05:09 AM EDT
1.66
-0.03 (-1.78%)
Earnings Announcements

Equillium Reports Third Quarter 2022 Financial Results, Provides Corporate, Clinical Updates

Published: 11/14/2022 21:23 GMT
Equillium Inc (EQ) - Equillium Reports Third Quarter 2022 Financial Results and Provides Corporate and Clinical Updates.
Equillium Inc - Initiated Phase 2 Study of Eq101 in Alopecia Areata and Phase 1 Study of Eq102 in Healthy Volunteers and Celiac Disease Patients.
Equillium - Believes Cash & Investments, Additional Cash Acquired With Expected Closing of Metacrine Deal, Will Be Enough to Fund Its Operations Into 2024.
Revenue is expected to be $0 Million
Adjusted EPS is expected to be -$0.33

Next Quarter Revenue Guidance is expected to be $0 Million
Next Quarter EPS Guidance is expected to be -$0.29

More details on our Analysts Page.